A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02057133 |
Recruitment Status :
Active, not recruiting
First Posted : February 6, 2014
Last Update Posted : March 25, 2024
|
Sponsor:
Eli Lilly and Company
Information provided by (Responsible Party):
Eli Lilly and Company
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | March 15, 2021 |
Estimated Study Completion Date : | December 31, 2024 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):